{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:59:30Z","timestamp":1794470370293,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"47","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Science and Technology Program grant"},{"name":"Sichuan Provincial Foundation of Science and Technology gran"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403965"],"award-info":[{"award-number":["82403965"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372836"],"award-info":[{"award-number":["82372836"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program gran"},{"name":"Sichuan Science and Technology Program gran"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,12,9]]},"DOI":"10.1038\/s41388-025-03601-y","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T15:51:40Z","timestamp":1761321100000},"page":"4657-4670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cytokine CCL2 secreted by cancer-associated fibroblasts augments temozolomide resistance in glioblastoma through ERK1\/2 signaling"],"prefix":"10.1038","volume":"44","author":[{"given":"Mingrong","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuze","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7446-3978","authenticated-orcid":false,"given":"Mina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3722-3334","authenticated-orcid":false,"given":"Yanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"3601_CR1","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noac161","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Ryan K, Edelson J, Neff C, Cioffi G, et al. CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. Neuro Oncol. 2022;24:iii1\u2013iii38.","journal-title":"Neuro Oncol"},{"key":"3601_CR2","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344:1396\u2013401.","journal-title":"Science"},{"key":"3601_CR3","first-page":"299","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA: ACancer J Clin. 2020;70:299\u2013312.","journal-title":"CA: ACancer J Clin"},{"key":"3601_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21117-3","volume":"12","author":"E Jung","year":"2021","unstructured":"Jung E, Osswald M, Ratliff M, Dogan H, Xie R, Weil S, et al. Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma. Nat Commun. 2021;12:1014.","journal-title":"Nat Commun"},{"key":"3601_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792\u2013804.","journal-title":"Nat Rev Clin Oncol"},{"key":"3601_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"3601_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41593-020-00770-9","volume":"24","author":"CE Dorrier","year":"2021","unstructured":"Dorrier CE, Aran D, Haenelt EA, Sheehy RN, Hoi KK, Pintaric L, et al. CNS fibroblasts form a fibrotic scar in response to immune cell infiltration. Nat Neurosci. 2021;24:234\u201344.","journal-title":"Nat Neurosci"},{"key":"3601_CR8","doi-asserted-by":"publisher","first-page":"721897","DOI":"10.3389\/fcell.2021.721897","volume":"9","author":"Z Chen","year":"2021","unstructured":"Chen Z, Zhuo S, He G, Tang J, Hao W, Gao WQ, et al. Prognosis and Immunotherapy Significances of a Cancer-Associated Fibroblasts-Related Gene Signature in Gliomas. Front Cell Dev Biol. 2021;9:721897","journal-title":"Front Cell Dev Biol"},{"key":"3601_CR9","doi-asserted-by":"publisher","first-page":"e147087","DOI":"10.1172\/JCI147087","volume":"133","author":"S Jain","year":"2023","unstructured":"Jain S, Rick JW, Joshi RS, Beniwal A, Spatz J, Gill S, et al. Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects. J Clin Investig. 2023;133:e147087.","journal-title":"J Clin Investig"},{"key":"3601_CR10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1158\/1078-0432.CCR-23-0493","volume":"30","author":"PM Galbo Jr","year":"2024","unstructured":"Galbo PM Jr, Madsen AT, Liu Y, Peng M, Wei Y, Ciesielski MJ, et al. Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma. Clin Cancer Res. 2024;30:865\u201376.","journal-title":"Clin Cancer Res"},{"key":"3601_CR11","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/ijc.22874","volume":"121","author":"HA Kenny","year":"2007","unstructured":"Kenny HA, Krausz T, Yamada SD, Lengyel E. Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int J cancer. 2007;121:1463\u201372.","journal-title":"Int J cancer"},{"key":"3601_CR12","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1038\/s41596-020-0402-9","volume":"15","author":"F Jacob","year":"2020","unstructured":"Jacob F, Ming G-l, Song H. Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing. Nat Protoc. 2020;15:4000\u201333.","journal-title":"Nat Protoc"},{"key":"3601_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51214-y","volume":"15","author":"M Wu","year":"2024","unstructured":"Wu M, Wang T, Ji N, Lu T, Yuan R, Wu L, et al. Multi-omics and pharmacological characterization of patient-derived glioma cell lines. Nat Commun. 2024;15:6740.","journal-title":"Nat Commun"},{"key":"3601_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28372-y","volume":"13","author":"N Abdelfattah","year":"2022","unstructured":"Abdelfattah N, Kumar P, Wang C, Leu J-S, Flynn WF, Gao R, et al. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun. 2022;13:767.","journal-title":"Nat Commun"},{"key":"3601_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: a J Integr Biol. 2012;16:284\u20137.","journal-title":"Omics: a J Integr Biol"},{"key":"3601_CR16","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic acids Res. 2016;44:e71. e.","journal-title":"Nucleic acids Res"},{"key":"3601_CR17","doi-asserted-by":"publisher","first-page":"e26476","DOI":"10.7554\/eLife.26476","volume":"6","author":"J Racle","year":"2017","unstructured":"Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017;6:e26476","journal-title":"Elife"},{"key":"3601_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/path.6207","volume":"262","author":"J Thorlacius-Ussing","year":"2024","unstructured":"Thorlacius-Ussing J, Jensen C, Nissen NI, Cox TR, Kalluri R, Karsdal M, et al. The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes. J Pathol. 2024;262:22\u201336.","journal-title":"J Pathol"},{"key":"3601_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41413-022-00203-2","volume":"10","author":"S Zhu","year":"2022","unstructured":"Zhu S, Chen M, Ying Y, Wu Q, Huang Z, Ni W, et al. Versatile subtypes of pericytes and their roles in spinal cord injury repair, bone development and repair. Bone Res. 2022;10:30.","journal-title":"Bone Res"},{"key":"3601_CR20","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1101\/gad.279737.116","volume":"30","author":"P Gascard","year":"2016","unstructured":"Gascard P, Tlsty TD. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev. 2016;30:1002\u201319.","journal-title":"Genes Dev"},{"key":"3601_CR21","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ccell.2021.06.017","volume":"39","author":"C Hutton","year":"2021","unstructured":"Hutton C, Heider F, Blanco-Gomez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;39:1227\u201344.e20.","journal-title":"Cancer Cell"},{"key":"3601_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA. The Microenvironmental Landscape of Brain Tumors. Cancer Cell. 2017;31:326\u201341.","journal-title":"Cancer Cell"},{"key":"3601_CR23","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41388-018-0461-3","volume":"38","author":"M Kato","year":"2019","unstructured":"Kato M, Placencio-Hickok VR, Madhav A, Haldar S, Tripathi M, Billet S, et al. Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner. Oncogene. 2019;38:716\u201330.","journal-title":"Oncogene"},{"key":"3601_CR24","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1038\/s41388-019-0765-y","volume":"38","author":"L Bu","year":"2019","unstructured":"Bu L, Baba H, Yoshida N, Miyake K, Yasuda T, Uchihara T, et al. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment. Oncogene. 2019;38:4887\u2013901.","journal-title":"Oncogene"},{"key":"3601_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms10305","volume":"7","author":"A Avgustinova","year":"2016","unstructured":"Avgustinova A, Iravani M, Robertson D, Fearns A, Gao Q, Klingbeil P, et al. Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness. Nat Commun. 2016;7:1\u201314.","journal-title":"Nat Commun"},{"key":"3601_CR26","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1093\/neuonc\/noae153","volume":"26","author":"N Luo","year":"2024","unstructured":"Luo N, Zhu W, Li X, Fu M, Zhang Y, Yang F, et al. Defective autophagy of pericytes enhances radiation-induced senescence promoting radiation brain injury. Neuro-Oncol. 2024;26:2288\u2013304.","journal-title":"Neuro-Oncol"},{"key":"3601_CR27","doi-asserted-by":"publisher","first-page":"e13265","DOI":"10.1111\/bpa.13265","volume":"34","author":"P Vymola","year":"2024","unstructured":"Vymola P, Garcia-Borja E, Cervenka J, Balaziova E, Vymolova B, Veprkova J, et al. Fibrillar extracellular matrix produced by pericyte-like cells facilitates glioma cell dissemination. Brain Pathol. 2024;34:e13265.","journal-title":"Brain Pathol"},{"key":"3601_CR28","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.3390\/ijms25105072","volume":"25","author":"M Martinez-Morga","year":"2024","unstructured":"Martinez-Morga M, Garrigos D, Rodriguez-Montero E, Pombero A, Garcia-Lopez R, Martinez S. Pericytes are immunoregulatory cells in glioma genesis and progression. Int J Mol Sci. 2024;25:5072.","journal-title":"Int J Mol Sci"},{"key":"3601_CR29","doi-asserted-by":"publisher","first-page":"2201888","DOI":"10.1002\/advs.202201888","volume":"9","author":"MT Ngo","year":"2022","unstructured":"Ngo MT, Sarkaria JN, Harley BAC. Perivascular stromal cells instruct glioblastoma invasion, proliferation, and therapeutic response within an engineered brain perivascular niche model. Adv Sci. 2022;9:2201888.","journal-title":"Adv Sci"},{"key":"3601_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41422-021-00528-3","volume":"31","author":"XN Zhang","year":"2021","unstructured":"Zhang XN, Yang KD, Chen C, He ZC, Wang QH, Feng H, et al. Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling. Cell Res. 2021;31:16.","journal-title":"Cell Res"},{"key":"3601_CR31","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.3390\/cancers14174251","volume":"14","author":"Z Shi","year":"2022","unstructured":"Shi Z, Tu J, Ying Y, Diao Y, Zhang P, Liao S, et al. CC chemokine ligand-2: a promising target for overcoming anticancer drug resistance. Cancers. 2022;14:4251.","journal-title":"Cancers"},{"key":"3601_CR32","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s41419-020-03111-7","volume":"11","author":"H Feng","year":"2020","unstructured":"Feng H, Liu K, Shen X, Liang J, Wang C, Qiu W, et al. Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer. Cell Death Dis. 2020;11:916.","journal-title":"Cell Death Dis"},{"key":"3601_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-021-02125-y","volume":"18","author":"M-A Dansereau","year":"2021","unstructured":"Dansereau M-A, Midavaine \u00c9, B\u00e9gin-Lavall\u00e9e V, Belkouch M, Beaudet N, Longpr\u00e9 J-M, et al. Mechanistic insights into the role of the chemokine CCL2\/CCR2 axis in dorsal root ganglia to peripheral inflammation and pain hypersensitivity. J Neuroinflamm. 2021;18:1\u201318.","journal-title":"J Neuroinflamm"},{"key":"3601_CR34","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/cbin.11778","volume":"46","author":"Y Qian","year":"2022","unstructured":"Qian Y, Ding P, Xu J, Nie X, Lu B. CCL2 activates AKT signaling to promote glycolysis and chemoresistance in glioma cells. Cell Biol Int. 2022;46:819\u201328.","journal-title":"Cell Biol Int"},{"key":"3601_CR35","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature11183","volume":"487","author":"R Straussman","year":"2012","unstructured":"Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature. 2012;487:500\u20134.","journal-title":"Nature"},{"key":"3601_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"3601_CR37","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","volume":"377","author":"GV Long","year":"2017","unstructured":"Long GV, Hauschild A, Santinami M, Atkinson V, Mandal\u00e0 M, Chiarion-Sileni V, et al. Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma. N Engl J Med. 2017;377:1813\u201323.","journal-title":"N Engl J Med"},{"key":"3601_CR38","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/1078-0432.CCR-19-2574","volume":"26","author":"A Varga","year":"2020","unstructured":"Varga A, Soria J-C, Hollebecque A, LoRusso P, Bendell J, Huang S-MA, et al. A First-in-Human Phase I Study to Evaluate the ERK1\/2 Inhibitor GDC-0994 in Patients with Advanced Solid TumorsERK1\/2 Inhibition in Advanced Solid Tumors. Clin Cancer Res. 2020;26:1229\u201336.","journal-title":"Clin Cancer Res"},{"key":"3601_CR39","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.aaw6985","volume":"364","author":"D Tuveson","year":"2019","unstructured":"Tuveson D, Clevers H. Cancer modeling meets human organoid technology. Science. 2019;364:952\u20135.","journal-title":"Science"},{"key":"3601_CR40","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","volume":"172","author":"S Su","year":"2018","unstructured":"Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172:841\u201356.e16.","journal-title":"Cell"},{"key":"3601_CR41","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.ccell.2021.09.003","volume":"39","author":"H Hu","year":"2021","unstructured":"Hu H, Piotrowska Z, Hare PJ, Chen H, Mulvey HE, Mayfield A, et al. Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms. Cancer Cell. 2021;39:1531\u201347.e10.","journal-title":"Cancer Cell"},{"key":"3601_CR42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer cell. 2018;33:463\u201379.e10.","journal-title":"Cancer cell"},{"key":"3601_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11060-011-0701-7","volume":"106","author":"A Clavreul","year":"2012","unstructured":"Clavreul A, Etcheverry A, Chassevent A, Quillien V, Avril T, Jourdan ML, et al. Isolation of a new cell population in the glioblastoma microenvironment. J Neuro-Oncol. 2012;106:493\u2013504.","journal-title":"J Neuro-Oncol"},{"key":"3601_CR44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/bjc.2017.15","volume":"116","author":"A Rochette","year":"2017","unstructured":"Rochette A, Boufaied N, Scarlata E, Hamel L, Brimo F, Whitaker HC, et al. Asporin is a stromally expressed marker associated with prostate cancer progression. Br J cancer. 2017;116:775\u201384.","journal-title":"Br J cancer"},{"key":"3601_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, Denardo DG, Werb Z. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:1\u201313.","journal-title":"Nat Rev Cancer"},{"key":"3601_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176613","volume":"134","author":"S Tripathi","year":"2024","unstructured":"Tripathi S, Najem H, Dussold C, Pacheco S, Miska J, McCortney K, et al. Cancer-associated fibroblast\u2013secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas. J Clin Investig. 2024;134:e176613.","journal-title":"J Clin Investig"},{"key":"3601_CR47","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/neuonc\/noaa107","volume":"22","author":"C Balana","year":"2020","unstructured":"Balana C, Vaz MA, Manuel Sep\u00falveda J, Mesia C, Del Barco S, Pineda E, et al. A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01). Neuro-Oncol. 2020;22:1851\u201361.","journal-title":"Neuro-Oncol"},{"key":"3601_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, He J, Li Y, Lv S, Cui H. NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR. Signal Transduct Target Ther. 2020;5:1\u201311.","journal-title":"Signal Transduct Target Ther"},{"key":"3601_CR49","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1093\/neuonc\/noac143","volume":"24","author":"ISC Verploegh","year":"2022","unstructured":"Verploegh ISC, Conidi A, Brouwer RWW, Balcioglu HE, Karras P, Makhzami S. et al. Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers. Neuro Oncol. 2022;24:2133\u20132145.","journal-title":"Neuro Oncol"},{"key":"3601_CR50","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.drup.2022.100913","volume":"66","author":"J Wu","year":"2023","unstructured":"Wu J, Zhou Z, Li J, Liu H, Zhang H, Zhang J, et al. CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK\/ERK axis. Drug Resistance Updates. 2023;66:100913.","journal-title":"Drug Resistance Updates"},{"key":"3601_CR51","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/neuonc\/noaa214","volume":"23","author":"Y Wei","year":"2021","unstructured":"Wei Y, Lu C, Zhou P, Zhao L, Lyu X, Yin J, et al. EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS\/MEK1\/ERK1\u20132 signaling. Neuro-Oncol. 2021;23:611\u201324.","journal-title":"Neuro-Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03601-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03601-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03601-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:02:32Z","timestamp":1763420552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03601-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":51,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025,12,9]]}},"alternative-id":["3601"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03601-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MZ and YL hold an authorized Chinese invention patent relating to the method of the primary CAFs culturing (ZL202111097340.7). Other authors reported no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures were performed in accordance with the ethical standards as outlined in the 1964 Declaration of Helsinki and its subsequent amendments, or with comparable ethical standards. All human tissues utilized in the present study were approved by the Ethics Committee on Biomedical Research, West China Hospital of Sichuan University (No.2021.1319), and attained written informed consent from patients or their legal guardians. All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of West China Hospital, Sichuan University, in compliance with the Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}